Parkinson`S Disease Equipment
-
based in USA
Parkinson’s disease is a neurodegenerative disorder that affects more than 6 million people worldwide. In most cases, the exact cause of Parkinson’s disease is unknown; however, mutations in GBA1, the gene that encodes the beta-glucocerebrosidase (GCase) enzyme, have been tied to the ...
-
Manufactured by BioArctic ABbased in SWEDEN
The antibody PD1601 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
-
Manufactured by BioArctic ABbased in SWEDEN
The antibody PD1602 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
-
Manufactured by BioArctic ABbased in SWEDEN
The drug candidate ABBV-0805 is a monoclonal antibody that selectively binds and eliminates oligomers and protofibrils of alpha-synuclein. The goal is to develop a disease modifying treatment that stops or slows down disease ...
-
Manufactured by Addex Therapeuticsbased in SWITZERLAND
We are developing mGlu4 PAM as a novel orally available treatment for Parkinson's disease. We are currently optimizing multiple chemical series of highly selective mGlu4 PAMs with compounds in early lead ...
-
based in USA
In cooperation with SUNY Upstate Medical University, Quadrant Biosciences is developing a non-invasive, saliva biomarker test highly accurate in characterizing Parkinson’s disease through an evaluation of human and oral microbiome transcripts ...
-
Manufactured by XPhyto Therapeutics Corporationbased in CANADA
Clinical studies are planned in 2021 to demonstrate the efficient transdermal delivery of a well-established Parkinson's disease ...
-
Manufactured by AnaSpecbased in USA
Parkinson's disease is predominantly a movement disorder resulting from degeneration of dopaminergic neurons in the substantia nigra. The cause of the disease is unknown, but substantial evidence suggests that the aggregation of α-synuclein is a critical step in the etiology of Parkinson's disease (PD). ...
-
Manufactured by Addex Therapeuticsbased in SWITZERLAND
mGlu2 NAM for the treatment of mild neurocognitive disorders, or mNCD. We are developing mGlu2 NAM as a novel orally available treatment for mNCD associated with Alzheimer’s disease, Parkinson’s disease and depressive disorders. The program is in clinical candidate selection phase and we expect to ...
-
by Pureims B.V.based in NETHERLANDS
Levodopa Cyclops™ is a levodopa dry powder inhaler for the fast and reliable relief of OFF episodes in Parkinson’s disease. As such, Levodopa Cyclops™ answers a major unmet medical need. Levodopa is the cornerstone in the treatment of Parkinson’s disease for well over 50 ...
-
Manufactured by Kaneka Eurogentec S.A.based in BELGIUM
α-Synuclein is a major component of Lewy bodies in the affected neurons in Parkinson's disease. This protein has a mass of 14.5 kDa (140 amino acids long) and consists of a conserved degenerative amino-terminal domain and an acidic carboxyl-terminal with higher sequence divergence. α-Synuclein is predominantly expressed in ...
-
Manufactured by MagQu LLC USAbased in USA
of substance. When tau proteins become defective, It will result in the self-assembly of tangles in brain and increased some neurodegenerative diseasesincluding Alzheimer’s disease (AD)?Pick's disease?Parkinson's disease (PD)?Progressive supranuclear palsy(PSP) and Corticobasal degeneration ...
-
Manufactured by Gerresheimer AGbased in GERMANY
This belt-worn on-body drug delivery device for small-molecule drugs has been developed for our pharma partner EVER Pharma. The wearable device is used by Parkinson's disease patients for the administration of apomorphine to treat this long-term degenerative disorder of the central nervous system. This device is customizable to be ...
-
Manufactured by Neuro Device Innovations (NDI)based in USA
TOPS technology was developed by Duke University Biomedical Engineering Professor, Dr. Warren Grill. After more than a decade of research, Professor Grill's lab discovered a way to 'speak' to the area of the brain that controls movement in people with Parkinson's disease. The stimulation patterns were designed to be more effective and/or ...
-
Manufactured by Shanghai Siyi Intelligent Technology Co., Ltdbased in CHINA
to walk. The artificial intelligence algorithm can adapt to the needs of the wearer. The best workhorse strategy. The soft exoskeleton is not limited to helping stroke patients. In the future, it can be used in cerebral palsy, Alzheimer's disease (senile dementia), multiple sclerosis, Parkinson's disease, and mobility problems in the elderly. ...
-
Manufactured by Shanghai Siyi Intelligent Technology Co., Ltdbased in CHINA
. In the future, it will be a life assistant for patients with stroke, spinal paralysis, arthritis, Parkinson's disease, and the ...
-
Manufactured by Valeo Pharma Inc.based in CANADA
The first Parkinson’s Disease (PD) treatment in Canada since 2006, providing relief of symptoms during the off-phase in dopamine treated ...
-
Manufactured by Alkahest, Inc.based in USA
Alkahest, with its partner Grifols, is developing lead clinical candidates, GRF6019 and GRF6021, as potential treatments for neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease with cognitive impairment. Designed to safely replenish regenerative positive ...
-
Manufactured by ReGen Therapeutics Limitedbased in UNITED KINGDOM
ReGen Therapeutics was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. The complex and the peptides within it are viewed as having potential utility in neurodegenerative illnesses such as Alzheimer’s disease, Parkinson’s ...
-
Manufactured by ACROBiosystemsbased in USA
Protein aggregation is a major pathological feature of neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). Under pathological conditions, Tau, Amyloid beta, alpha-synuclein, TDP-43, Huntingtin and other proteins ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you